Pharma Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Business & Finance
Drug delivery-focused company receives notice of AMEX delisting
February 27th, 2006
Access Pharmaceuticals, Inc., (AKC) announced its receipt of an American Stock Exchange (AMEX) Listing Qualifications Department determination denying the company's appeal of an AMEX Staff Determination on December 12, 2005 which found that the company failed to comply with AMEX's continued listing standards due to losses from continuing operations and/or net losses in two of its most recent fiscal years with shareholders' equity of less than $2 million. This is set forth in Section 1003(a)(i) of the AMEX "Company Guide"; due to losses from continuing operations and/or net losses in 3 of its most recent fiscal years with shareholders' equity of less than $4 million, as...
Source: Pharma Business Week (2006-02-27)
|
